Your search returned 4 results.

Results
	1.	Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review. [electronic resource] by Sparano, Francesco Aaronson, Neil K Sprangers, Mirjam A G Fayers, Peter Pusic, Andrea Kieffer, Jacobien M Cottone, Francesco Rees, Jonathan Pezold, Mike Anota, Amelie Charton, Emilie Vignetti, Marco Wan, Chonghua Blazeby, Jane Efficace, Fabio Producer: 20200225 In: BMJ supportive & palliative care vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration-resistant prostate cancer. [electronic resource] by Fenioux, Charlotte Louvet, Christophe Charton, Emilie Rozet, Francois Ropert, Stanislas Prapotnich, Dominique Barret, Eric Sanchez-Salas, Rafael Mombet, Annick Cathala, Nathalie Joulia, Marie-Liesse Molitor, Jean-Luc Henriques, Julie Bonnetain, Franck Cathelineau, Xavier Bennamoun, Mostefa Producer: 20190927 In: BJU international vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial. [electronic resource] by Charton, Emilie Bachet, Jean-Baptiste Hammel, Pascal Desramé, Jérôme Chibaudel, Benoist Cohen, Romain Debourdeau, Philippe Dauba, Jérome Lecomte, Thierry Seitz, Jean-François Tournigand, Christophe Aparicio, Thomas Guerin-Meyer, Véronique Taieb, Julien Volet, Julien Louvet, Christophe Anota, Amélie Bonnetain, Franck Producer: 20200902 In: Cancer medicine vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial. [electronic resource] by Eberst, Guillaume Anota, Amélie Scherpereel, Arnaud Mazieres, Julien Margery, Jacques Greillier, Laurent Audigier-Valette, Clarisse Moro-Sibilot, Denis Molinier, Olivier Léna, Hervé Rivière, Frédéric Monnet, Isabelle Gounant, Valérie Janicot, Henri Gervais, Radj Locher, Chrystelle Charton, Emilie Morin, Franck Zalcman, Gérard Westeel, Virginie Producer: 20200925 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)